7-phenylethylamino-4h-pyrimido [4,5-d] [1,3] oxazin-2-one compounds as mutant idh1 and idh2 inhibitors

• 收藏
• 分享

专利权人:

ELI LILLY AND COMPANY

发明人:

PATRIC JAMES HAHN,RAYMOND GILMOUR,RENATO ALEJANDRO BAUER,SERGE LOUIS BOULET,TIMOTHY PAUL BURKHOLDER,ZORAN RANKOVIC

申请号：

BR112019009648

公开号：

BR112019009648A2

申请日:

2017.12.08

申请国别(地区):

BR

年份:

2019

代理人:

摘要：

The present invention relates to a compound as defined herein or a pharmaceutical composition containing the compound for use in the treatment of mutant idh1 or idh2 cancer and having the structure:a presente invenção refere-se a um composto, como definido aqui, ou composição farmacêutica contendo o composto, para uso no tratamento de câncer de idh1 ou idh2 mutante e tendo a estrutura:

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/